PTK2 and colorectal carcinoma: As it is impossible to determine the predominant signaling pathway between RAF and FAK in relation to the proliferation and survival of CRC cells, and RAF or FAK signaling pathways can complement each other for cancer cell proliferation and survival, the binary distinction must not be acceptable.